Scandion Oncology
Overcoming cancer drug resistance

Navbar

Research & Development
News & Press
- Press releases
Investors

Skip to content

3 June 2019

Watch the presentation from Småbolagsdagen 2019 in Stockholm

CEO Nils Brünner presented at the investor meeting Småbolagsdagen 2019 in Stockholm:

Posted in NewsTagged News

Post navigation

Scandion Oncology presents at the investor meeting Småbolagsdagen 2019 in Stockholm

Scandion Oncology appoints Chairman and Vice-Chairman of its Board of Directors

Frontpage
Press releases
Watch the presentation from Småbolagsdagen 2019 in Stockholm

About us

Research & Development

Research & Development
Pipeline
Clinical Development
Science

News & Press

Press releases
Other news
Image library items
Video library items

Investors

Investors
Share information
Financial Reports
Presentations
Analyst Coverage
Prospectuses
Corporate governance
Events

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.